Diagnosis, etiology and management of the Budd-Chiari Syndrome: a bloodcoagulation and hepatological study on the course of the disease treated with TIPS.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Angiology

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 26138237
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of Budd-Chiari: a single-center experience of 280 cases.

  2014cited by this paper
• Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk‐guided management

  2013cited by this paper
• Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.

  2012cited by this paper
• Influence of the secondary deployment of expanded polytetrafluoroethylene-covered stent grafts on maintenance of transjugular intrahepatic portosystemic shunt patency.

  2011cited by this paper
• Long‐term follow‐up of patients with portal vein thrombosis and myeloproliferative neoplasms

  2011cited by this paper
• High levels of factor VIII and risk of extra-hepatic portal vein obstruction.

  2009cited by this paper
• Etiology, management, and outcome of the Budd-Chiari syndrome.

  2009cited by this paper
• Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms

  2009cited by this paper
• JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.

  2009cited by this paper
• TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients.

  2008cited by this paper
• Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

  2008cited by this paper
• Interventional Radiology in the Management of Budd Chiari Syndrome

  2008cited by this paper
• Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis

  2008cited by this paper
• The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases.

  2008cited by this paper
• Inherited thrombophilic abnormalities and risk of portal vein thrombosis

  2008cited by this paper
• Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation

  2008cited by this paper
• Prognostic Factors in Noncirrhotic Patients With Splanchnic Vein Thromboses

  2007cited by this paper
• Aiming at minimal invasiveness as a therapeutic strategy for Budd‐Chiari syndrome

  2006cited by this paper
• Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres.

  2006cited by this paper
• Transjugular intrahepatic portosystemic shunt patency and clinical outcome in patients with Budd-Chiari syndrome: covered versus uncovered stents.

  2006cited by this paper
• Pathogenesis and Treatment of Budd-Chiari Syndrome Combined with Portal Vein Thrombosis

  2006cited by this paper
• Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin.

  2006cited by this paper
• Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome.

  2005cited by this paper
• Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.

  2004cited by this paper
• Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature.

  2004cited by this paper
• Determinants of survival and the effect of portosystemic shunting in patients with Budd‐Chiari syndrome

  2004cited by this paper
• Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective analysis of 15 patients.

  2003cited by this paper
• Budd-Chiari syndrome: a review by an expert panel.

  2003cited by this paper
• Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE‐covered stentgrafts versus bare stents

  2003cited by this paper
• Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy.

  2001cited by this paper
• Hereditary thrombophilia as a cause of Budd‐Chiari syndrome: A study from Western India

  2001cited by this paper
• Extrahepatic portal vein thrombosis: aetiology and determinants of survival

  2001cited by this paper
• Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors

  2000cited by this paper
• Outcome of Budd‐Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shunting

  1999cited by this paper
• Spontaneous Erythroid Colony Formation as the Clue to an Underlying Myeloproliferative Disorder in Patients with Budd-Chiari Syndrome or Portal Vein Thrombosis

  1997cited by this paper
• The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases.

  1994cited by this paper
• Diagnosis of portal vein thrombosis: value of color Doppler imaging.

  1991cited by this paper

• Budd-Chiari syndrome treated with direct intrahepatic portocaval shunt: A case report

  2024influential citation
• Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasms

  2021cites this paper
• Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN‐associated portal hypertension

  2017cites this paper
• 69 ) Budd-Chiari Syndrome

  2017cites this paper
• Long‐term outcomes following percutaneous hepatic vein recanalization for Budd–Chiari syndrome

  2017cites this paper
• Budd-Chiari Syndrome.

  2017cites this paper
• Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)

  2017cites this paper
• Successful Treatment of Budd-Chiari Syndrome with Balloon Dilatation Angioplasty

  2016cites this paper